Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Inventory (2019 - 2025)

Historic Inventory for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $44228.0.

  • Bioadaptives' Inventory changed N/A to $44228.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $44228.0, marking a year-over-year change of. This contributed to the annual value of $19115.0 for FY2024, which is 2509.0% up from last year.
  • Bioadaptives' Inventory amounted to $44228.0 in Q3 2025.
  • Over the past 5 years, Bioadaptives' Inventory peaked at $44228.0 during Q3 2025, and registered a low of $3572.0 during Q1 2022.
  • Its 5-year average for Inventory is $15014.8, with a median of $10124.0 in 2021.
  • As far as peak fluctuations go, Bioadaptives' Inventory crashed by 7093.34% in 2022, and later skyrocketed by 55956.67% in 2025.
  • Quarter analysis of 5 years shows Bioadaptives' Inventory stood at $4750.0 in 2021, then skyrocketed by 86.88% to $8877.0 in 2022, then surged by 72.14% to $15281.0 in 2023, then grew by 25.09% to $19115.0 in 2024, then skyrocketed by 131.38% to $44228.0 in 2025.
  • Its Inventory stands at $44228.0 for Q3 2025, versus $39574.0 for Q2 2025 and $40584.0 for Q1 2025.